This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Media can register now for ESTRO 36 - Europe's largest congress on radiation oncology

March 1st, 2017

Registration has now opened for journalists for ESTRO 36 - Europe's largest congress on radiation oncology, organised by the European Society for Radiotherapy and Oncology (ESTRO).

ESTRO 36 takes place at the Reed Messe Vienna GmbH, Congress Centre, Messeplatz 1, A-1021 Vienna, Austria, 5 - 9 May 2017. Registration is free for journalists on provision of bona fide press credentials.

The ESTRO 36 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists, radiation therapists and cancer nurses from all over the world, working together for the benefit of cancer patients.

The congress is expected to attract 5,000 delegates from more than 80 countries.

The congress will cover the entire spectrum of radiotherapy, both external beam and internal beam with brachytherapy, and highlight what is new across fields as diverse as:

  • state-of-the-art breast brachytherapy
  • combination radiotherapy and targeted agents
  • radiotherapy and health economics
  • how to select the right patients for proton therapy in Europe
  • emerging technologies in particle therapy
  • long-term effects in cancer survivors
  • targeted therapy, stem cells, and normal tissue toxicity

Provided by European Society for Radiotherapy and Oncology

Citation: Media can register now for ESTRO 36 - Europe's largest congress on radiation oncology (2017, March 1) retrieved 10 July 2026 from https://sciencex.com/wire-news/249829216/media-can-register-now-for-estro-36-europes-largest-congress-o.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.